LDL and apoB
CETP and PLTP activity, not diabetes itself, drive elevated cholesteryl ester transfer in NIDDM (Atherosclerosis 1998)
Original title: Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein
Plasma cholesteryl ester transfer (CET), cholesterol esterification rate, and LCAT and PLTP activities were compared between 16 men with non-insulin-dependent diabetes mellitus (NIDDM) and 16 matched healthy men. NIDDM patients showed higher CET, esterification rate, LCAT, and PLTP activity (P<0.05 to P<0.02), along with higher triglycerides and lower HDL cholesterol and cholesteryl ester (P<0.01 and P<0.05). Multiple stepwise regression showed CET was positively related to VLDL plus LDL cholesterol (P<0.001), triglycerides (P=0.001), PLTP activity (P=0.007), and CETP activity (P=0.008, multiple r=0.94), with NIDDM itself having no independent effect on CET once these parameters were accounted for. HDL cholesteryl ester was negatively related to CET, hepatic lipase activity, and NIDDM, and positively to LCAT activity (multiple r=0.68). The authors conclude that elevated CET in NIDDM reflects higher triglycerides and PLTP and CETP activity levels rather than diabetes per se.
Original abstract
Lecithin:cholesteryl acyl transferase (LCAT) and cholesteryl ester transfer protein (CETP) are key factors in the esterification of cholesterol and the subsequent transfer of cholesteryl ester from high density lipoproteins (HDL) towards very low and low density lipoproteins (VLDL + LDL). Phospholipid transfer protein (PLTP), lipoprotein lipase (LPL) and hepatic lipase (HL) are involved in plasma phospholipid and triglyceride metabolism and also affect HDL. Equivocal changes in plasma cholesteryl ester transfer have been reported in non-insulin-dependent diabetes mellitus (NIDDM). In 16 NIDDM men with plasma triglycerides < or = 4.5 mmol/l and cholesterol < or = 8.0 mmol/l. plasma cholesteryl ester transfer (CET), cholesterol esterification rate, LCAT and PLTP activity levels were higher (P < 0.05 to P < 0.02) in conjunction with higher plasma triglycerides (P < 0.01) and lower HDL cholesterol and cholesteryl ester levels (P < 0.05) compared to 16 matched healthy men. Multiple stepwise regression analysis demonstrated that CET was positively related to VLDL + LDL cholesterol (P < 0.001), triglycerides (P = 0.001), PLTP activity (P = 0.007) and CETP activity (P = 0.008, multiple r = 0.94). NIDDM had no effect on CET, independently from these parameters. HDL cholesteryl ester was negatively related to CET (P= 0.017), HL activity (P = 0.033) and NIDDM (P = 0.047) and positively to LCAT activity levels (P = 0.034, multiple r = 0.68). It is concluded that the elevated CET in plasma from NIDDM patients is associated with higher plasma triglycerides and PLTP activity levels. Furthermore, our data suggest that in normo- and moderately dyslipidaemic subjects PLTP and CETP activity levels per se may influence the rate of cholesteryl ester transfer in plasma. Plasma cholesteryl ester transfer appears to be a determinant of HDL cholesteryl ester, but other factors are likely to contribute to lower HDL cholesteryl ester levels in NIDDM.
diabetesHDL biologyLDL and apoB
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.